{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:39:45Z","timestamp":1787668785828,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19-AI113127"],"award-info":[{"award-number":["U19-AI113127"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P30-MH43520"],"award-info":[{"award-number":["P30-MH43520"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10461-018-2336-6","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T12:15:10Z","timestamp":1541852110000},"page":"1484-1493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche"],"prefix":"10.1007","volume":"23","author":[{"given":"Alex","family":"Carballo-Dieguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-0550","authenticated-orcid":false,"given":"Rebecca","family":"Giguere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Dolezal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,10]]},"reference":[{"issue":"27","key":"2336_CR1","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399. \n                    https:\/\/doi.org\/10.1056\/NEJM0a1011205\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"23","key":"2336_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1506273\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"7","key":"2336_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11095-016-1904-6","volume":"33","author":"E Schlesinger","year":"2016","unstructured":"Schlesinger E, Johengen D, Luecke E, et al. A tunable, biodegradable, thin-film polymer device as long-acting implant delivering tenofovir alafenamide fumarate for HIV pre-exposure prophylaxis. Pharm Res. 2016;33(7):1649\u201356. \n                    https:\/\/doi.org\/10.1007\/s11095-016-1904-6\n                    \n                  .","journal-title":"Pharm Res"},{"issue":"6","key":"2336_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/COH.0000000000000002","volume":"8","author":"WR Spreen","year":"2013","unstructured":"Spreen WR, Margolis DA, Pottage JC Jr. Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS. 2013;8(6):565\u201371. \n                    https:\/\/doi.org\/10.1097\/COH.0000000000000002\n                    \n                  .","journal-title":"Curr Opin HIV AIDS."},{"issue":"4","key":"2336_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/apc.2012.0419","volume":"27","author":"SA Golub","year":"2013","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248\u201354. \n                    https:\/\/doi.org\/10.1089\/apc.2012.0419\n                    \n                  .","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"2336_CR6","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1007\/s10461-017-1969-1","volume":"21","author":"A Carballo-Di\u00e9guez","year":"2017","unstructured":"Carballo-Di\u00e9guez A, Giguere R, Dolezal C, et al. Preference of oral tenofovir disoproxil fumarate\/emtricitabine versus rectal tenofovir reduced-glycerin 1% gel regimens for HIV prevention among cisgender men and transgender women who engage in receptive anal intercourse with men. AIDS Behav. 2017;21(12):3336\u201345. \n                    https:\/\/doi.org\/10.1007\/s10461-017-1969-1\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"4","key":"2336_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/1545109712473650","volume":"12","author":"J Peinado","year":"2013","unstructured":"Peinado J, Lama JR, Galea JT, et al. Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru. J Int Assoc Provid AIDS Care. 2013;12(4):278\u201383. \n                    https:\/\/doi.org\/10.1177\/1545109712473650\n                    \n                  .","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"12","key":"2336_CR8","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.vaccine.2005.11.013","volume":"24","author":"PA Newman","year":"2006","unstructured":"Newman PA, Duan N, Lee SJ, et al. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine. 2006;24(12):2094\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.013\n                    \n                  .","journal-title":"Vaccine"},{"issue":"11","key":"2336_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/QAD.0b013e32833adbe8","volume":"24","author":"PA Newman","year":"2010","unstructured":"Newman PA, Logie C. HIV vaccine acceptability: a systematic review and meta-analysis. AIDS. 2010;24(11):1749\u201356. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e32833adbe8\n                    \n                  .","journal-title":"AIDS."},{"issue":"22","key":"2336_CR10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332. \n                    https:\/\/doi.org\/10.1056\/nejmoa1506110\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9","key":"2336_CR11","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1007\/s10461-014-0793-0","volume":"18","author":"A Carballo-Di\u00e9guez","year":"2014","unstructured":"Carballo-Di\u00e9guez A, Giguere R, Dolezal C, et al. Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally. AIDS Behav. 2014;18(9):1734\u201345. \n                    https:\/\/doi.org\/10.1007\/s10461-014-0793-0\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"2","key":"2336_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s10461-017-1890-7","volume":"22","author":"R Giguere","year":"2018","unstructured":"Giguere R, Rael CT, Sheinfil A, et al. Factors supporting and hindering adherence to rectal microbicide gel use with receptive anal intercourse in a Phase 2 trial. AIDS Behav. 2018;22(2):388\u2013401. \n                    https:\/\/doi.org\/10.1007\/s10461-017-1980-7\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"2","key":"2336_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10461-017-1847-x","volume":"22","author":"JA Bauermeister","year":"2018","unstructured":"Bauermeister JA, Giguere R, Leu CS, et al. Patterns of rectal microbicide placebo gel use in a preparatory stage for a Phase 1 trial among young men who have sex with. men. AIDS Behav. 2018;22(2):412\u201320. \n                    https:\/\/doi.org\/10.1007\/s10461-017-1847-x\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"1","key":"2336_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1521\/aeap.2016.28.1.1","volume":"28","author":"J Bauermeister","year":"2016","unstructured":"Bauermeister J, Giguere R, Dolezal C, et al. To use a rectal microbicide, first insert the applicator: gel and applicator satisfaction among young men who have sex with men. AIDS Educ Prev. 2016;28(1):1\u201310. \n                    https:\/\/doi.org\/10.1521\/aeap.2016.28.1.1\n                    \n                  .","journal-title":"AIDS Educ Prev"},{"issue":"10","key":"2336_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/00007435-199911000-00006","volume":"26","author":"M Gross","year":"1999","unstructured":"Gross M, Celum C, Tabet SR, Clifton K, Coletti AS, Chesney MA. Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999;26(10):572\u20138.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"2336_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s10461-007-9301-0","volume":"12","author":"A Carballo-Di\u00e9guez","year":"2008","unstructured":"Carballo-Di\u00e9guez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008;12(6):860\u20136. \n                    https:\/\/doi.org\/10.1007\/s10461-007-9301-0\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"4","key":"2336_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/OLQ.0b013e3181bj9b2d","volume":"37","author":"A Carballo-Di\u00e9guez","year":"2010","unstructured":"Carballo-Di\u00e9guez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K. Why rectal douches may be acceptable rectal-microbicide delivery vehicles for MSM. Sex Transm Dis. 2010;37(4):228\u201333. \n                    https:\/\/doi.org\/10.1097\/OLQ.0b013e3181bj9b2d\n                    \n                  .","journal-title":"Sex Transm Dis"},{"issue":"4","key":"2336_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s10461-017-1959-3","volume":"22","author":"A Carballo-Di\u00e9guez","year":"2018","unstructured":"Carballo-Di\u00e9guez A, Lentz C, Giguere R, Fuchs EJ, Hendrix CW. Rectal douching associated with receptive anal intercourse: a literature review. AIDS Behav. 2018;22(4):1288\u201394. \n                    https:\/\/doi.org\/10.1007\/s10461-017-1959-3\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"2","key":"2336_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/apc.2012.0355","volume":"27","author":"SK Calabrese","year":"2013","unstructured":"Calabrese SK, Rosenberger JG, Schick VR, Novak DS, Reece M. An event-level comparison of risk-related sexual practices between black and other-race men who have sex with men: condoms, semen, lubricant and rectal douching. AIDS Patient Care STDS. 2013;27(2):77\u201384. \n                    https:\/\/doi.org\/10.1089\/apc.2012\/0355\n                    \n                  .","journal-title":"AIDS Patient Care STDS."},{"key":"2336_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-95","volume":"14","author":"M Javanbakht","year":"2014","unstructured":"Javanbakht M, Stahlman S, Pickett J, Leblanc MA, Gorbach PM. Prevalence and types of rectal douches used for anal intercourse: results from an international survey. BMC Infect Dis. 2014;14:1\u20138. \n                    https:\/\/doi.org\/10.1186\/1471-2334-14-95\n                    \n                  .","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2336_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/sextrans-2016-052777","volume":"93","author":"RCA Achterbergh","year":"2017","unstructured":"Achterbergh RCA, vann der Helm JJ, van den Boom W, et al. Is rectal douching and sharing douching equipment associated with anorectal chlamydia and gonorrhea? A cross-sectional study among men who have sex with men. Sex Transm Infect. 2017;93(6):431\u20137. \n                    https:\/\/doi.org\/10.1136\/sextrans-2016-052777\n                    \n                  .","journal-title":"Sex Transm Infect."},{"issue":"1","key":"2336_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/sextrans-2013-051154","volume":"90","author":"JT Galea","year":"2014","unstructured":"Galea JT, Kinsler JJ, Imrie J, Nure\u00f1a CR, S\u00e1nchez J, Cunningham WE. Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: a qualitative study. Sex Transm Infect. 2014;90(1):33\u20135. \n                    https:\/\/doi.org\/10.1136\/sextrans-2013-051154\n                    \n                  .","journal-title":"Sex Transm Infect."},{"issue":"11","key":"2336_CR23","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1007\/s10461-015-1250-4","volume":"20","author":"JW Mitchell","year":"2016","unstructured":"Mitchell JW, Sophus AI, Lee J-Y, Petroll AE. Anal douche practices and willingness to use a rectal microbicide enema for HIV prevention and associated factors among an Internet sample of HIV-negative and HIV-discordant male couples in the US. AIDS Behav. 2016;20(11):2578\u201387. \n                    https:\/\/doi.org\/10.1007\/s10461-015-1250-4\n                    \n                  .","journal-title":"AIDS Behav"},{"issue":"11","key":"2336_CR24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1089\/aid.2013.0189","volume":"29","author":"FJ Leyva","year":"2013","unstructured":"Leyva FJ, Bakshi RP, Fuchs EJ, et al. Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides. AIDS Res Hum Retroviruses. 2013;29(11):1487\u201395. \n                    https:\/\/doi.org\/10.1089\/AID.2013.0189\n                    \n                  .","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2336_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jconrel.2015.04.040","volume":"209","author":"K Maisel","year":"2015","unstructured":"Maisel K, Chattopadhyay S, Moench T, et al. Enema ion compositions for enhancing colorectal drug delivery. J Control Release. 2015;209:280\u20137.","journal-title":"J Control Release"},{"key":"2336_CR26","unstructured":"Weld ED, Fuchs E, Marzinke M, et al. Tenofovir enema as HIV PrEP for receptive anal intercourse: Safety, pharmacokinetics, pharmacodynamics and acceptability (DREAM 01). [MOLBPEC33] Presented at the 9th International AIDS Society Conference on HIV Science; 2017; Paris."},{"key":"2336_CR27","unstructured":"United States Census Bureau. QuickFacts United States. U.S. Department of Commerce. \n                    https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045217#viewtop\n                    \n                  . Accessed 29 March 2018."},{"issue":"6","key":"2336_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/COH.0b013e3283590632","volume":"7","author":"BS Mensch","year":"2012","unstructured":"Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534\u201341. \n                    https:\/\/doi.org\/10.1097\/COH.0b013e3283590632\n                    \n                  .","journal-title":"Curr Opin HIV AIDS."},{"key":"2336_CR29","unstructured":"Miskell P. How Crest made business history. Harvard Business School: Working Knowledge. \n                    https:\/\/hbswk.hbs.edu\/archive\/how-crest-made-business-history\n                    \n                  . Accessed 12 April 2018."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2336-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-018-2336-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2336-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:00:06Z","timestamp":1589716806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-018-2336-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,10]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1007\/s10461-018-2336-6","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,10]]},"assertion":[{"value":"10 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}